About
Troy Wilson co-founded Kura Oncology, Inc. in 2014 and serves as its President, Chief Executive Officer, and Chairman of the Board. He previously co-founded and led Avidity Biosciences, Araxes Pharma, Wellspring Biosciences, Intellikine, and Ambrx, several of which were acquired by companies including Takeda, Johnson & Johnson, and Novartis, and he currently sits on the boards of Atrium Therapeutics, Puma Biotechnology, Cartography Biosciences, Montara Therapeutics, and Cipher Genetics. Wilson holds a J.D. from New York University and a Ph.D. in bioorganic chemistry and B.A. in biophysics from the University of California, Berkeley.
Founder at Kura Oncology
Intro paths
In turn, Troy can intro founders to Kura Oncology's investors below.
Kura Oncology's investors Β· 6
Co-founders at Kura Oncology
Experience
- Kura Oncology, Inc.President, Chief Executive Officer and Chairman of the Boardcurrent2014 β presentLa Jolla, California and Cambridge, Massachusetts
- Atrium TherapeuticsBoard Membercurrent2026 β presentSan Diego, CA
- Montara Therapeutics, Inc.Chairman of the Board of Directorscurrent2025 β present
- Cartography BiosciencesChairman of the Board of Directorscurrent2024 β presentSouth San Francisco, CA
- Araxes Pharma, LLCSole Managing Membercurrent2012 β presentSan Diego, CA
- Puma BiotechnologyMember Board of Directorscurrent2013 β presentLos Angeles, California
- Avidity Biosciences, Inc.Chair of the Board of Directors2020 β 2026La Jolla, California
- Avidity Biosciences, Inc.Executive Chairman2019 β 2020
- Avidity Biosciences, Inc.President, CEO and Co-Founder2013 β 2019San Diego, California
- Wellspring BiosciencesExecutive Chairman2019 β 2023San Diego
- Wellspring BiosciencesPresident, Chief Executive Officer, Chairman and Co-Founder2012 β 2019San Diego, California, United States
- IntellikinePresident, CEO and Co-Founder2007 β 2012La Jolla, California
- Wildcat Discovery TechnologiesPresident and Co-Founder2006 β 2007San Diego, California
- AmbrxChief Business Officer and Co-Founder2003 β 2006La Jolla, California
- GNFVice President, Business Development and General Counsel2000 β 2003
Skills & more
+11 more
Clinical DevelopmentDrug DevelopmentDrug DiscoveryVenture CapitalR&DCell CultureDue DiligenceEntrepreneurshipCommercializationBusiness StrategyPharmaceutical IndustryFrom Troy's professional profile.
Frequently asked questions
- Who is Troy Wilson?
- Troy Wilson co-founded Kura Oncology, Inc. in 2014 and serves as its President, Chief Executive Officer, and Chairman of the Board. He previously co-founded and led Avidity Biosciences, Araxes Pharma, Wellspring Biosciences, Intellikine, and Ambrx, several of which were acquired by companies including Takeda, Johnson & Johnson, and Novartis, and he currently sits on the boards of Atrium Therapeutics, Puma Biotechnology, Cartography Biosciences, Montara Therapeutics, and Cipher Genetics. Wilson holds a J.D. from New York University and a Ph.D. in bioorganic chemistry and B.A. in biophysics from the University of California, Berkeley.
- Where does Troy Wilson work?
- Troy Wilson is Founder of Kura Oncology.
- What companies did Troy Wilson found?
- Troy Wilson founded Kura Oncology.
- Where did Troy Wilson go to school?
- Troy Wilson studied at New York University School of Law (J.D., Law); University of California, Berkeley (Ph.D., Biorganic Chemistry).
Same school
Also attended New York University School of Law61
+ 55 more
Also attended University of California, Berkeley1,453
+ 1,447 more






%20(1).png)










